BFM
DARE icon

Boothbay Fund Management’s Dare Bioscience DARE Stock Holding History

Boothbay Fund Management’s Portfolio DARE Stock Details DARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,528
Closed -$26K – 770
2019
Q1 		$26K Sell
1,528
-1,418
-48% -$16.5K ﹤0.01% 719
2018
Q4 		$25K Hold
2,946
– – ﹤0.01% 612
2018
Q3 		$34K Hold
2,946
– – ﹤0.01% 755
2018
Q2 		$41K Hold
2,946
– – ﹤0.01% 711
2018
Q1 		$30K Buy
+2,946
New +$59.6K ﹤0.01% 672

Other funds holding DARE

PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
FFS
Founders Financial Securities Towson, Maryland $1.77B AUM 17.63% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
EWM
Edge Wealth Management New York $594M AUM 24.92% 1-Year Est. Return

Boothbay Fund Management's DARE Position: Q2 2019 in Review

Boothbay Fund Management sold out of Dare Bioscience (DARE) in Q2 2019, closing a stake of 1,528 shares — an estimated $26K sold.

Boothbay Fund Management first reported a position in DARE in Q1 2018 and held it in 5 quarters. The position peaked at $41K in Q2 2018. 14 funds tracked by Wall St. Rank hold DARE as of Q2 2019.

  • Boothbay Fund Management reported no remaining Dare Bioscience position as of Q2 2019 after selling out during the quarter.
  • Boothbay Fund Management sold 1,528 Dare Bioscience shares in Q2 2019, an estimated $26K.
  • Boothbay Fund Management first reported a position in Dare Bioscience in Q1 2018 and held it in 5 quarters.
  • Boothbay Fund Management's Dare Bioscience position peaked at $41K in Q2 2018.
  • 14 funds tracked by Wall St. Rank held Dare Bioscience as of Q2 2019.

Based on Boothbay Fund Management's 13F filing for Q2 2019, filed 14 Aug 2019.